Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) announced today the pricing of its underwritten registered public offering of 2,750,000 shares of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE